- Home
- HE vs HRMY Comparison
HE vs HRMY Comparison
Compare HE & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HE
- HRMY
- Stock Information
- Founded
- HE 1891
- HRMY 2017
- Country
- HE United States
- HRMY United States
- Employees
- HE N/A
- HRMY N/A
- Industry
- HE Electric Utilities: Central
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- HE Utilities
- HRMY Health Care
- Exchange
- HE Nasdaq
- HRMY Nasdaq
- Market Cap
- HE 1.8B
- HRMY 2.0B
- IPO Year
- HE N/A
- HRMY 2020
- Fundamental
- Price
- HE $9.17
- HRMY $39.05
- Analyst Decision
- HE Hold
- HRMY Strong Buy
- Analyst Count
- HE 3
- HRMY 8
- Target Price
- HE $10.67
- HRMY $55.00
- AVG Volume (30 Days)
- HE 3.5M
- HRMY 593.9K
- Earning Date
- HE 02-11-2025
- HRMY 02-20-2025
- Dividend Yield
- HE N/A
- HRMY N/A
- EPS Growth
- HE N/A
- HRMY N/A
- EPS
- HE N/A
- HRMY 2.11
- Revenue
- HE $3,689,272,000.00
- HRMY $681,879,000.00
- Revenue This Year
- HE $3.17
- HRMY $24.79
- Revenue Next Year
- HE N/A
- HRMY $19.00
- P/E Ratio
- HE N/A
- HRMY $18.55
- Revenue Growth
- HE N/A
- HRMY 25.83
- 52 Week Low
- HE $7.61
- HRMY $28.14
- 52 Week High
- HE $18.19
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- HE 44.97
- HRMY 71.30
- Support Level
- HE $9.69
- HRMY $35.72
- Resistance Level
- HE $10.01
- HRMY $37.16
- Average True Range (ATR)
- HE 0.37
- HRMY 1.29
- MACD
- HE -0.00
- HRMY 0.48
- Stochastic Oscillator
- HE 54.23
- HRMY 92.25
About HE Hawaiian Electric Industries Inc.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.